A Tailored, Web-Based Self-Management Program to Treat Pain in Chronic Pancreatitis
1 other identifier
interventional
31
1 country
1
Brief Summary
This research study aims to evaluate the feasibility and acceptability of a web-based, self-guided, disease-specific self-management program tailored to individual health status profiles for patients with painful chronic pancreatitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2025
CompletedFirst Posted
Study publicly available on registry
November 3, 2025
CompletedStudy Start
First participant enrolled
December 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2026
CompletedMay 1, 2026
April 1, 2026
5 months
October 29, 2025
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Proportion of enrolled participants that log in at least once during weeks 1-4 and at least once to the recommended modules during weeks 5-12.
This number is used to determine adherence to the intervention.
12 weeks
Proportion of participants with an average item score of ≥4 out of 5 on the Acceptability of Healthcare Interventions Questionnaire
This is a validated 8-item questionnaire that assesses acceptability using a 5-point Likert scale rated 1-5.
12 weeks
Secondary Outcomes (7)
Proportion of participants approached that enroll in the study.
Approximately 1 year (during recruitment period)
Proportion of enrolled participants that log in at least once during the 12-week program
12 weeks
Proportion of enrolled participants that log in at least once a week during weeks 1-4 and at least once a week to the recommended modules during weeks 5-12.
12 weeks
Number of logins per participant during the 12-week intervention
12 weeks
Proportion of fully completed questionnaires by the total number given to participants
12 weeks
- +2 more secondary outcomes
Study Arms (1)
Web-based self-management program
EXPERIMENTALParticipants will be assigned to a web-based, self-management program that has been adapted to chronic pancreatitis. Participants will participate in this program for 12 weeks.
Interventions
Participants in this study will be granted access to the adapted website after participants complete baseline questionnaires. All participants will be encouraged to engage with all the sections of the website. From week 1 to 4, participants will receive a single standardized guidance to complete one module a week on generic pain modules. From weeks 5 to 12, participants will receive weekly tailored messaging that will direct participants to specific modules based on individual survey scores from the baseline assessments.
Eligibility Criteria
You may qualify if:
- Physician diagnosis of chronic pancreatitis.
- Abdominal pain for ≥ 3 months and of intensity rated at least 4 or higher on a 0-10 Numeric Rating Scale at least once in the last month.
- Access to an Internet-connected device (e.g. computer or phone).
You may not qualify if:
- Unable to speak or read English as the web-based program is currently in English language only.
- Incarcerated individuals.
- Currently receiving chemotherapy.
- Suspected or diagnosed pancreatic cancer.
- Currently receiving psychotherapy or cognitive behavioral therapy.
- Serious visual difficulties that would limit completing the web-based program.
- Substantial cognitive impairment or mental illness that would prevent providing informed consent and completion of questionnaires.
- Any other condition, which in the opinion of the investigator would impede compliance or hinder the completion of the study.
- Actively enrolled in another clinical trial for chronic pancreatitis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jorge Machicado, MD, MPH
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
October 29, 2025
First Posted
November 3, 2025
Study Start
December 4, 2025
Primary Completion
April 28, 2026
Study Completion
April 28, 2026
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share